Published in:
01-01-2014 | Fertility Preservation
Fertility preservation after caesarean delivery in a woman diagnosed with Morbus Hodgkin disease during pregnancy
Authors:
Theresa Gundelach, Diane Stuck, Peter Widschwendter, Jürgen M. Weiss, Wolfgang Janni, Katharina Hancke
Published in:
Journal of Assisted Reproduction and Genetics
|
Issue 1/2014
Login to get access
Excerpt
Female fertility preservation before chemotherapy has become a common issue among postpubertal and premenopausal women who desire children. Von Wolff et al. [
1] recently published a practical guideline for different fertility preservation techniques, based on data from the FertiPROTEKT network database. The published practical guideline particularly addresses women with breast cancer, Hodgkin disease, or borderline ovarian tumour. The following are the different fertility preservation techniques covered: (1) hormonal stimulation and cryopreservation of unfertilised and fertilised oocytes, (2) cryopreservation of ovarian tissue, and (3) administration of gonadotropin-releasing hormone agonists (GnRHa). There is one or more than 1 option available for cancer patients, depending on cancer type, partnership, and individual desire. …